News
AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Artificial ...
22h
Vietnam Investment Review on MSNNature Medicine Publishes Innovent s Promising Phase 1 Gastric Cancer DataInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
14h
The Christian Post on MSN3 Doors Down frontman shares update amid cancer diagnosis: 'God will fight this battle for me'Brad Arnold, frontman for the Grammy-nominated rock band 3 Doors Down, shared a hopeful health update with fans and expressed ...
Nadunolimab added to carboplatin and gemcitabine (GC) did not impact the safety profile of the chemotherapy and was well tolerated ...
13h
News-Medical.Net on MSNSpecially engineered antibody delivers RNA therapy to treatment-resistant tumorsA specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...
A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors ...
Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.
Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...
Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...
Panelists discuss how managing amivantamab-related adverse events such as leg edema requires understanding of underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results